Perhaps one of the most frequently asked questions by the parents of children whose seizures are well controlled, is if-and when-medication can be discontinued. Many reasons may prompt this question; the need to continue taking drugs when the seizures appear to have stopped, the inconvenience of having to take-or give-regular medication even if only once a day, the development of not only recognized but also potentially un-recognized side-effects (specifically on concentration, learning and behaviour) and the emotional and psychological implications of having to take medication which contributes to the real (or perceived) stigmatisation of epilepsy. In contrast, the reasons for continuing antiepileptic medication may appear to be less obvious. These include not wishing to 'rock the boat' in a child who is seizure-free and who appears to be functioning well both academically and socially, the largely unfounded concern that control may not be re-gained if seizures recur following drug withdrawal and the continuing debate as to whether antiepileptic drug therapy may alter the natural history of the epilepsy and prevent the development of chronic epilepsy 1 .
The question of drug withdrawal is obviously important and although the decision to stop an anticonvulsant may ultimately depend on the personal (including emotional) feelings of the parents and the child, arguments based on medical evidence may have a role in influencing this decision. Numerous studies, including the one by Altunbasak et al. 15 in this issue of Seizure have attempted to provide such evidence on which to base the decision to withdraw antiepileptic drugs in children who have been seizurefree. These studies have also tried to identify specific factors which may be associated with an increased risk of seizure relapse following drug-withdrawal. A meta-analysis of 25 drug-withdrawal studies involving 5434 adults and children showed that the overall seizure relapse rate was 25% at one year and 29% at two years following withdrawal of an anticonvulsant; in children, the relapse rate was slightly lower and in adolescents, slightly higher 2 . Unfortunately, although a meta-analysis is of academic interest, it is of little relevance or assistance for the individual clinician or family.
The current recommended or usual practice is that drug withdrawal should be considered after a child has been seizure-free for two years. The source of this recommendation is unclear but may have originated from a comment made by Lennox and Lennox in 1960 who suggested that '. . .when from one to three years have passed without symptoms, the dose may be reduced' 3 . Support for this recommendation subsequently came from a study which showed no difference in the relapse rate (25%) for children who had been seizurefree for either two or four years, prior to withdrawal of the anticonvulsant 4 . However, there is some evidence that a longer period of seizure-freedom may be associated with a lower relapse rate 5 . A study of 154 children demonstrated that, two years after withdrawing their anticonvulsant, 54% were seizure-free in whom the drug had been discontinued after one year of seizure-freedom compared with 71% whose drug was withdrawn after three years of seizure-freedom 5 . In a Canadian study of 97 children whose anticonvulsant had been discontinued after only one year of seizurefreedom, 61% had remained seizure free at a two-year follow-up; the authors felt that this figure was similar to previous studies in which children had been seizure-free for longer prior to drug withdrawal 6 . Finally, a more recent study suggested that the duration of seizure-freedom may not necessarily be important in determining the relapse rate 7 . In this Dutch prospective randomized study, 78 children had their anticonvulsant withdrawn after six months of being seizurefree and the remaining 83 children had their drug discontinued after one year of seizure-freedom; the relapse rate was almost identical in both groups (51%), two years after discontinuing the drug 7 .
Factors which appear to be associated with an increased risk of relapse are largely predictablesymptomatic epilepsy (i.e. a definite aetiology), accompanying neurological or developmental problems, multiple seizure types, a long duration of epilepsy prior to seizure control and a failure to achieve seizurecontrol with the first antiepileptic drug. The age of onset is also important with an age of onset of <3 or >12 years increasing the chance of a relapse. The role of the electroencephalogram (EEG) in predicting a relapse is unclear with some studies suggesting that it may 8, 9 or may not 4 be of predictive value. The issue is further compounded by what exactly comprises an 'abnormal' EEG. Finally, some drug withdrawal studies 10 , including the one by Altunbasak et al. , have only included children in whom the EEG was normal prior to withdrawal, while most other studies have subsequently used EEG findings as a specific factor when attempting to predict the risk of a recurrence. The MRC Antiepileptic Drug Withdrawal Study identified seven prognostic factors, including an abnormal EEG, which were then used to generate a statistical model for patients who had been in remission for at least two years 11 . Although this model was designed to be of use in everyday clinical practice, the determination of the prognostic index and percentage risk is not that practicable and may be of little relevance for the vast majority of parents (and teenagers) who want to know whether they can, or should, stop treatment. A more recent paediatric study has suggested a prognostic model which could identify children in whom treatment could be withdrawn after one year of seizure-freedom 12 . Many parents either do not understand what a seizure recurrence risk of 90% means, no matter how simply it is defined, and of those that do understand, many would consider that this risk is worth taking if they (or their child) have a 10% chance of remaining seizure-free after the anticonvulsant has been stopped. Obviously, these perceptions may be influenced by a number of factors including the type(s) and frequency of seizures prior to achieving control, how easy or difficult it was to obtain seizure-control and for teenagers, whether they have, or are about to obtain a driving licence.
The major deficiency of all these drug-withdrawal studies, including those which provide predictive or prognostic models, is that the majority have failed to assess relapse rates, or seizure-freedom according to specific epilepsy syndromes 13 , rather than simply 'epilepsy' or, occasionally, seizure types 12 . This is somewhat surprising given the relative senescence of the original ILAE Classification of the epilepsies and epilepsy syndromes 14 . Future studies which attempt to evaluate the rate of seizure relapse and the associated risk factors following drug withdrawal, must do so on the basis of the child's specific epilepsy syndrome. This should hopefully provide more meaningful evidence with which to inform the parents of these children-as well as the children themselves-as to the likelihood of remaining seizure-free following discontinuation of their anticonvulsant. For example, although juvenile myoclonic epilepsy is recognized to have a high relapse rate, it would be clinically useful to identify if there are any specific features of this syndrome which are not associated with a relapse following drug withdrawal. A similar approach should be adopted for syndromes which generally have low relapse rates, including childhood-onset typical absence epilepsy.
However, it is perhaps unrealistic and even somewhat naive to imagine that this approach will be the major factor in influencing either the parents (or teenagers with epilepsy), when faced with the opportunity and decision to discontinue treatment. As Lennox and Lennox commented, 'Those who advise continuance for life give all credit to the drug and none to natural healing forces in the body. The frequency with which seizures stop 'of their own accord' discredits their view. The inconvenience, expense and psychological dependence of drug-taking should not be continued unnecessarily. An electrographic examination may be informative, but actual trial of being without medicine is the final test' 3 . For many families, and teenagers, the opportunity of 'being without medicine' may provide the most practical and compelling reason and will frequently militate against scientific argument when discussing the withdrawal of an antiepileptic drug.
